
Customize View
Recently disclosed strategic alliances only (within the last two years)
Include Strategic Alliances for:Current subsidiaries



Strategic Alliances

Recently Disclosed Strategic Alliances
Strategic Alliance Name
Primary Industry
Source
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Health Care Facilities
Helix BioPharma Corp. (TSX:HBP) 2022 Form Doc
Business Description: H. Lee Moffitt Cancer Center & Research Institute, Inc. operates as a cancer treatment and research center. It offers private patient rooms, blood and marrow transplant programs, outpatient treatment programs, patient care, research, and education services. Additionally, it publishes Today's Tomorrows, a community newsletter about cancer care, research, and education. H. Lee Moffitt Cancer Center & Research Institute, Inc. was incorporated in 1984 and is based in Tampa, Florida.
ProMab Biotechnologies, Inc.
Biotechnology
Helix BioPharma Corp. (TSX:HBP) 2021 Form Doc
Business Description: ProMab Biotechnologies, Inc., a biotechnology company, develops and commercializes recombinant proteins and custom monoclonal antibodies through the integration of bioinformatics, gene cloning, protein expression and purification, and immunology. Its products include cancer stem cell/iPSCs, cell/exosome isolation, and labware. The company also provides small molecules custom antibody, additional monoclonal antibody, phospho-specific custom antibody, and in-vitro monoclonal antibody services; and other additional services, such as peptide synthesis, screening, ascites production, antibody purification, and labeling. In addition, it offers custom antibody services, including custom monoclonal antibodies, hybridoma sequencing, and custom polyclonal antibodies. The company is based in Richmond, California.
*denotes proprietary relationship